Clinical Trial Update: Alleviating the Metabolic Side Effects of Antipsychotic Medications [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating methods to alleviate metabolic side effects of antipsychotic medications has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Baker Heart and Diabetes Institute | Conditions: Schizophrenia | Phase 4 | Status: WITHDRAWN